OBJECTIVE: To examine the clinical outcome of percutaneous coronary intervention where the procedure was complicated by vessel perforation. SETTING: Tertiary referral centre. METHODS: The procedural records of 6245 patients undergoing coronary intervention were reviewed. In 52 patients (0.8%) the procedure was complicated by vessel perforation, ranging from wire exit to free flow of contrast into the pericardial space. The majority of lesions treated were complex (37% type B, 59% type C) and 9 of 52 (17%) were chronic occlusions. Ten patients (19%) received abciximab. Four underwent rotational atherectomy (8%). RESULTS: In 28 of 52 patients (54%) the perforation was benign and managed conservatively without the development of haemodynamically significant sequelae. In 24 of 52 (46%) a significant pericardial effusion ensued requiring drainage. Of these 24 procedures 6 had involved the treatment of a chronic occlusion (25%). Eight of the 24 patients were referred for emergency bypass surgery (33%), 3 of whom died. Of the remaining 16 not referred for surgery, 3 died. Of the 10 procedures complicated by vessel perforation where abciximab had been administered, 9 (90%) led to pericardial tamponade. Latterly 2 vessel perforations were successfully treated by the deployment of a covered stent. CONCLUSIONS: Coronary artery perforation with sequelae during intervention is rare--26 of 6245 (0.4%). This complication was seen in the treatment of chronic occlusions, which are therefore not risk-free procedures. The development of pericardial tamponade carries a high mortality. While prompt surgical intervention may be life saving, expertise in the use of covered stents may provide a valuable rescue option for this serious complication. Caution should be exercised where coronary perforation occurs and abciximab has been used.
OBJECTIVE: To examine the clinical outcome of percutaneous coronary intervention where the procedure was complicated by vessel perforation. SETTING: Tertiary referral centre. METHODS: The procedural records of 6245 patients undergoing coronary intervention were reviewed. In 52 patients (0.8%) the procedure was complicated by vessel perforation, ranging from wire exit to free flow of contrast into the pericardial space. The majority of lesions treated were complex (37% type B, 59% type C) and 9 of 52 (17%) were chronic occlusions. Ten patients (19%) received abciximab. Four underwent rotational atherectomy (8%). RESULTS: In 28 of 52 patients (54%) the perforation was benign and managed conservatively without the development of haemodynamically significant sequelae. In 24 of 52 (46%) a significant pericardial effusion ensued requiring drainage. Of these 24 procedures 6 had involved the treatment of a chronic occlusion (25%). Eight of the 24 patients were referred for emergency bypass surgery (33%), 3 of whom died. Of the remaining 16 not referred for surgery, 3 died. Of the 10 procedures complicated by vessel perforation where abciximab had been administered, 9 (90%) led to pericardial tamponade. Latterly 2 vessel perforations were successfully treated by the deployment of a covered stent. CONCLUSIONS: Coronary artery perforation with sequelae during intervention is rare--26 of 6245 (0.4%). This complication was seen in the treatment of chronic occlusions, which are therefore not risk-free procedures. The development of pericardial tamponade carries a high mortality. While prompt surgical intervention may be life saving, expertise in the use of covered stents may provide a valuable rescue option for this serious complication. Caution should be exercised where coronary perforation occurs and abciximab has been used.
Authors: L Gruberg; E Pinnow; R Flood; Y Bonnet; M Tebeica; R Waksman; L F Satler; A D Pichard; K M Kent; M B Leon; J Lindsay Journal: Am J Cardiol Date: 2000-09-15 Impact factor: 2.778
Authors: H Reinecke; T Fetsch; N Roeder; C Schmid; A Winter; M Ribbing; E Berendes; M Block; H H Scheld; G Breithardt; S Kerber Journal: Ann Thorac Surg Date: 2000-12 Impact factor: 4.330
Authors: E J Topol; R M Califf; H F Weisman; S G Ellis; J E Tcheng; S Worley; R Ivanhoe; B S George; D Fintel; M Weston Journal: Lancet Date: 1994-04-09 Impact factor: 79.321
Authors: Fabio Settecase; Marshall S Sussman; Mark W Wilson; Steven Hetts; Ronald L Arenson; Vincent Malba; Anthony F Bernhardt; Walter Kucharczyk; Timothy P L Roberts Journal: Med Phys Date: 2007-08 Impact factor: 4.071
Authors: Georgios Dimitrakakis; Ulrich Otto Von Oppell; Subramaniam Balachandran; Agamemnon Pericleous; Richard Anderson Journal: Int J Angiol Date: 2013-12
Authors: Andrea Grohmann; Thomas Elgeti; Stephan Eddicks; Fabian Knebel; Wolfgang Rutsch; Christoph Melzer; Gert Baumann; Adrian C Borges Journal: Cardiovasc Ultrasound Date: 2008-01-16 Impact factor: 2.062